Endoglin negatively regulates transforming growth factor beta1-induced profibrotic responses in intestinal fibroblasts.
AffiliationDepartment of Surgery, St Vincent's University Hospital, Dublin, Ireland.
Aged, 80 and over
Receptors, Cell Surface/metabolism/*physiology
Transforming Growth Factor beta1/*metabolism
MetadataShow full item record
CitationBr J Surg. 2010 Jun;97(6):892-901.
JournalThe British journal of surgery
AbstractBACKGROUND: Fibroblasts isolated from strictures in Crohn's disease (CD) exhibit reduced responsiveness to stimulation with transforming growth factor (TGF) beta1. TGF-beta1, acting through the smad pathway, is critical to fibroblast-mediated intestinal fibrosis. The membrane glycoprotein, endoglin, is a negative regulator of TGF-beta1. METHODS: Intestinal fibroblasts were cultured from seromuscular biopsies of patients undergoing intestinal resection for CD strictures or from control patients. Endoglin expression was assessed using confocal microscopy, flow cytometry and western blot. The effect of small interfering (si) RNA-mediated knockdown and plasmid-mediated overexpression of endoglin on fibroblast responsiveness to TGF-beta1 was assessed by examining smad phosphorylation, smad binding element (SBE) promoter activity, connective tissue growth factor (CTGF) expression and ability to contract collagen. RESULTS: Crohn's stricture fibroblasts expressed increased constitutive cell-surface and whole-cell endoglin relative to control cells. Endoglin co-localized with filamentous actin. Fibroblasts treated with siRNA directed against endoglin exhibited enhanced TGF-beta1-mediated smad-3 phosphorylation, and collagen contraction. Cells transfected with an endoglin plasmid did not respond to TGF-beta1 by exhibiting SBE promoter activity or producing CTGF. CONCLUSION: Fibroblasts from strictures in CD express increased constitutive endoglin. Endoglin is a negative regulator of TGF-beta1 signalling in the intestinal fibroblast, modulating smad-3 phosphorylation, SBE promoter activity, CTGF production and collagen contraction.
- Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts.
- Authors: Burke JP, Cunningham MF, Watson RW, Docherty NG, Coffey JC, O'Connell PR
- Issue date: 2010 Jul
- Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
- Authors: Burke JP, Watson RW, Murphy M, Docherty NG, Coffey JC, O'Connell PR
- Issue date: 2009 May
- Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
- Authors: Shyu KG, Wang BW, Chen WJ, Kuan P, Hung CR
- Issue date: 2010 Mar
- N-cadherin is overexpressed in Crohn's stricture fibroblasts and promotes intestinal fibroblast migration.
- Authors: Burke JP, Cunningham MF, Sweeney C, Docherty NG, O'Connell PR
- Issue date: 2011 Aug
- Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.
- Authors: Mulsow JJ, Watson RW, Fitzpatrick JM, O'Connell PR
- Issue date: 2005 Dec